Walleye Trading’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Walleye Trading’s Portfolio OCRX Stock Details OCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-100	Closed	–	–	5824
2016 Q2	$0	Sell	100 -100	-50%	-$263	﹤0.01%	6010
2016 Q1	$1K	Buy	+200	New	+$571	﹤0.01%	5235

Other funds holding OCRX

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Walleye Trading's OCRX Position: Q3 2016 in Review

Walleye Trading sold out of Ocera Therapeutics, Inc. (OCRX) in Q3 2016, closing a stake of 100 shares.

Walleye Trading first reported a position in OCRX in Q1 2016 and held it in 2 quarters. The position peaked at $1K in Q1 2016. 31 funds tracked by Wall St. Rank hold OCRX as of Q3 2016.

Walleye Trading reported no remaining Ocera Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
Walleye Trading sold 100 Ocera Therapeutics, Inc. shares in Q3 2016.
Walleye Trading first reported a position in Ocera Therapeutics, Inc. in Q1 2016 and held it in 2 quarters.
Walleye Trading's Ocera Therapeutics, Inc. position peaked at $1K in Q1 2016.
31 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q3 2016.

Based on Walleye Trading's 13F filing for Q3 2016, filed 14 Nov 2016.